Clinical Trial Update: Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial in metastatic pancreatic cancer compared gemcitabine-erlotinib with gemcitabine-erlotinib-capecitabine to evaluate safety and efficacy, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED